No risk, no fun: Investing in innovation – Insights from a Venture Capital expert
Venture Capital tends to invest in innovation and disruption, therefore backs relatively young companies at the forefront of new developments which are shaping the future of an industry. Venture Capital carries its name for a reason, the asset class is not with-out risks for investors, who should bring a very entrepreneurial attitude and / or stra-tegic interest to the table. On the other hand – multiples for finding the ‘next unicorn’ will be more than rewarding and usually exceed potential write offs within the invest-ment portfolio. Dr. Birner will explain the mechanics of Venture Capital as an asset class, particularly focusing on lifescience and healthcare investments. He will draw from the wealth of the TVM Capital Life Science’s experience of global venture capital investing spanning more than 30 years.